Kepivance PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Palifermin (Kepivance PowerPoint PPT Presentation
Palifermin (Kepivance - Patients: B-NHL receiving COP/COPADM/CYM. Age 3-16 years ... COP/COPADM/CYM: multi-agent chemotherapy regimen. Phase 1. Dose escalation, 4 dose cohorts ...
Patients: B-NHL receiving COP/COPADM/CYM. Age 3-16 years ... COP/COPADM/CYM: multi-agent chemotherapy regimen. Phase 1. Dose escalation, 4 dose cohorts ...
| PowerPoint PPT presentation | free to view
FEDERAL LABORATORY CONSORTIUM PowerPoint PPT Presentation
FEDERAL LABORATORY CONSORTIUM - ... EXCELLENCE IN TECHNOLOGY TRANSFER AWARD ... ENERGY TECHNOLOGY LABORATORY. JIMMY THORNTON BENJAMIN CHORPENING. DOUGLAS ... OF SURGICAL RESEARCH. ERIC ...
... EXCELLENCE IN TECHNOLOGY TRANSFER AWARD ... ENERGY TECHNOLOGY LABORATORY. JIMMY THORNTON BENJAMIN CHORPENING. DOUGLAS ... OF SURGICAL RESEARCH. ERIC ...
| PowerPoint PPT presentation | free to view
NIH Partnering with Maryland Companies PowerPoint PPT Presentation
NIH Partnering with Maryland Companies - Collaborating with NIH Scientists. Material Transfer Agreements. Clinical Trial Agreements ... NIH scientist presentations to companies. Facilitating access to ...
Collaborating with NIH Scientists. Material Transfer Agreements. Clinical Trial Agreements ... NIH scientist presentations to companies. Facilitating access to ...
| PowerPoint PPT presentation | free to view
PREVENTION DE LIATROPATHOLOGIE LIEE A LA CHIMIOTHERAPIE ANTICANCEREUSE PowerPoint PPT Presentation
PREVENTION DE LIATROPATHOLOGIE LIEE A LA CHIMIOTHERAPIE ANTICANCEREUSE - L'apparition des effets ind sirables est d pendante de plusieurs facteurs : ... Etoposide connu pour provoquer des leuc mies aigues my loblastiques (LAM) ...
L'apparition des effets ind sirables est d pendante de plusieurs facteurs : ... Etoposide connu pour provoquer des leuc mies aigues my loblastiques (LAM) ...
| PowerPoint PPT presentation | free to view
BIO2009 Federal Science and Opportunities Track PowerPoint PPT Presentation
BIO2009 Federal Science and Opportunities Track - Peptides/Proteins Nucleic Acids/Vectors Assays Small Molecules Animal Models Antibodies Cell Lines Libraries ... heart disease, cancer, hepatitis, and autoimmune ...
Peptides/Proteins Nucleic Acids/Vectors Assays Small Molecules Animal Models Antibodies Cell Lines Libraries ... heart disease, cancer, hepatitis, and autoimmune ...
| PowerPoint PPT presentation | free to view
BIO2009 Federal Science and Opportunities Track PowerPoint PPT Presentation
BIO2009 Federal Science and Opportunities Track - ... research being conducted at Federal laboratories in the field of Biotechnology ... Hot Federal Biotechnologies Available for Collaboration and Licensing ...
... research being conducted at Federal laboratories in the field of Biotechnology ... Hot Federal Biotechnologies Available for Collaboration and Licensing ...
| PowerPoint PPT presentation | free to view
Biovitrum Building the biopharma company of tomorrow PowerPoint PPT Presentation
Biovitrum Building the biopharma company of tomorrow - Pre-clinical & clinical. Small molecules. and proteins. Stockholm (SBT) Cambridge (CBT) ... Clinical Development. to be met by outsourcing. An Integrated ...
Pre-clinical & clinical. Small molecules. and proteins. Stockholm (SBT) Cambridge (CBT) ... Clinical Development. to be met by outsourcing. An Integrated ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
kepivance — Search results on PowerShow.com